Roche sues Credit Suisse for alleged securities fraud
This article was originally published in Scrip
Executive Summary
Roche has sued Credit Suisse Group AG in the US, alleging that two former directors, later charged with fraud, engaged in a scheme to put more than $545 million of the pharmaceutical manufacturer's funds into risky and unauthorised auction rate securities.